Porton Biopharma appoints Pinsent Masons as lead legal adviser
22 Dec 2015 | 02:47 pm |
International law firm Pinsent Masons has been appointed as lead legal adviser to Porton Biopharma Limited following a competitive tender process.
The team will provide a full range of specialist legal services in IP, employment, property, pensions, procurement, health and safety, commercialisation, and government, commercial and corporate advice.
The relationship continues following the firms' recent work for the Department of Health in establishing Porton Biopharma as a limited liability company, to commercialise the pharmaceutical development and manufacturing capabilities at the Porton Down site that were previously within Public Health England.
Louise Fullwood, legal director at Pinsent Masons said, "The appointment will enable us to support Porton Biopharma with a broad range of legal services. This, combined with our specialist knowledge of the sector, paves the way for a long-term, strategic working relationship."
This appointment exemplifies the combination of Pinsent Mason’s key strengths in life sciences and in public sector advice.
Key Contacts
Latest press releases
Show me all press releasesPinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland
Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.
Pinsent Masons advises on Four Seasons Care Homes portfolio migration
Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.
Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.
Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland
Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.
Pinsent Masons advises on Four Seasons Care Homes portfolio migration
Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]